| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/16/2002 | CN1331290A Polypeptide-human beta-1,4 galactosyltransferase 18.59 and polynucleotide for coding it |
| 01/16/2002 | CN1331250A Glucoprotein having inhibitory activity to pyroric spirillar colonization |
| 01/16/2002 | CN1331248A Polypeptide-human chondral connexin 10.67 and polynucleotide for coding it |
| 01/16/2002 | CN1331246A Polypeptide-human cytochrome C oxidase subunit 8.91 and polynucleotide for coding it |
| 01/16/2002 | CN1331243A Polypeptide-human myoglobulin IXA 11.88 and polynucleotide for coding it |
| 01/16/2002 | CN1331237A Polypeptide-human myotube protein 10.56 and polynucleotide for coding it |
| 01/16/2002 | CN1331236A Polypeptide-human myoglobulin heavy chain B22.22 and polynucleotide for coding it |
| 01/16/2002 | CN1331231A Polypeptide-human macroprotein 10.12 and polynucleotide for coding it |
| 01/16/2002 | CN1331229A Polypeptide-human macroprotein 9.24 and polynucleotide for coding it |
| 01/16/2002 | CN1331228A Polypeptide-human neural cell adhesion molecule 11.44 and polynucleotide for coding it |
| 01/16/2002 | CN1331227A Polypeptide-human EHD protein 12.1 and polynucleotide for coding it |
| 01/16/2002 | CN1331226A Polypeptide-human transcription factor LCR-F112.1 and polynucleotide for coding it |
| 01/16/2002 | CN1331222A Polypeptide-human zinc finger protein 44 and polynucleotide for coding it |
| 01/16/2002 | CN1331218A Polypeptide-human zinc finger protein 12.98 and polynucleotide for coding it |
| 01/16/2002 | CN1331216A Polypeptide-human vacuolus hydrion ATP enzyme 36.08 and polynucleotide for coding it |
| 01/16/2002 | CN1331210A Polypeptide-human acidic fibroid protocell growth factor binding factor 10.78 and polynucleotide for coding it |
| 01/16/2002 | CN1331208A Polypeptide-human tumor necrosis factor receptor 21.45 and polynucleotide for coding it |
| 01/16/2002 | CN1331202A Polypeptide-human estrogenic receptor associated protein 10.01 and polynucleotide for coding it |
| 01/16/2002 | CN1331199A Polypeptide-human transcription growth regulatory factor beta activator protein 14.08 and polynucleotide for coding it |
| 01/16/2002 | CN1331188A Polypeptide-human cytokine receptor 10.67 and polynucleotide for coding it |
| 01/16/2002 | CN1331187A Polypeptide-human zinc finger protein 8.8 and polynudeotide for coding it |
| 01/16/2002 | CN1331183A Polypeptide-human DNA repair protein 10.23 and polynucleotide for coding it |
| 01/16/2002 | CN1331174A Polypeptide-human Zinc finger protein 10.45 and polynucleotide for coding it |
| 01/16/2002 | CN1331163A Polypeptide-human transcription regulator factor 2FM1 isomer 19.47 and polynucleotide for coding it |
| 01/16/2002 | CN1331161A Polypeptide-human transcription factor LCR-F19.02 and polynucleotide for coding it |
| 01/16/2002 | CN1331156A Polypeptide-human neurofibroma complification protein 9.24 and polynucleotide for coding it |
| 01/16/2002 | CN1331125A Polypeptide-human TNFR-NGFR protein 9.02 containing cytochrome C structure domain and polynucleotide for coding it |
| 01/16/2002 | CN1331119A Polypeptide-human FK506 bindin 13.42 and polynucleotide for coding it |
| 01/16/2002 | CN1331114A Polypeptide-MGC-2413.31 and polynucleotide for coding it |
| 01/16/2002 | CN1331096A Polypeptide-cytokine signal inhibitor SOCS-5-29 and polynucleotide for coding it |
| 01/16/2002 | CN1331086A Polypeptide-ring finger gene MID 1 protein 10.56 and polynucleotide for coding it |
| 01/16/2002 | CN1331083A Memory-improving peptides and their application |
| 01/16/2002 | CN1330955A Instant particles for regulating growth and trace element absorption of human bone |
| 01/16/2002 | CN1077800C Cyclosporin soft capsule compsn. |
| 01/16/2002 | CN1077799C prevention of retinal injury and degeneration by specfic factors |
| 01/16/2002 | CN1077798C Pharmaceutical compsn. |
| 01/15/2002 | US6339160 For therapy of tumoral growth and metastatization, aterosclerosis, multiple sclerosis, alzheimer's disease, osteoporosis, hypertension, rheumatoid arthritis and other inflammatory diseases |
| 01/15/2002 | US6339150 Mutant rex genes encoding transdominant repressors of HIV/HTLV replication |
| 01/15/2002 | US6339149 Isolated nucleic acid molecules which encode tumor rejection antigens found in dage |
| 01/15/2002 | US6339142 Protein purification |
| 01/15/2002 | US6339141 Interleukin-1 Hy2 materials and methods |
| 01/15/2002 | US6339139 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 01/15/2002 | US6339071 For preventing proliferation of tumor cells |
| 01/15/2002 | US6339070 Gene directed enzyme prodrug therapy (gdept) using in situ antibody generation to provide enhanced selectivity, in cancer therapy; for delivering cytotoxic drugs |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6339066 Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
| 01/15/2002 | US6339065 Episomal expression vector for human gene therapy |
| 01/15/2002 | US6339062 Retroinverso polypeptides that mimic or inhibit thrombospondin activity |
| 01/15/2002 | US6338958 Integrin-linked kinase and its uses |
| 01/15/2002 | US6338953 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 01/15/2002 | US6338950 DNA encoding LST-1 protein and process for recombinant production of LST-1 protein |
| 01/15/2002 | US6338949 A non-genomic recombinant dna; diagnosis and therapy for hairy cell leukemia, viral hepatitis, autoimmune diseases and graft rejection |
| 01/15/2002 | US6338851 Method of suppressing an immune response to a transplanted organ or tissue by administering an OX-2 protein |
| 01/15/2002 | US6338850 Administering immunosuppressive dosage of plant tissue and purification |
| 01/15/2002 | US6338848 Treating multiple sclerosis with immunoglobulins and interleukins |
| 01/15/2002 | US6338845 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 01/15/2002 | US6338844 Genomic nucleic acids, cDNA and mRNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 01/15/2002 | CA2121604C Diagnosis and treatment of bacterial dysentery |
| 01/15/2002 | CA2109304C Glycosylated prodrugs, and their processes of preparation and use |
| 01/15/2002 | CA2089143C Growth factor compositions, preparation and use |
| 01/15/2002 | CA2050946C Use of polysaccharides in preparations for wound treatment |
| 01/15/2002 | CA2036894C Vectors and compounds for expression of glycosylation mutants of human protein c |
| 01/15/2002 | CA2030951C Process for producing immunostimulant agents |
| 01/15/2002 | CA2022444C Lhrh analogs |
| 01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
| 01/13/2002 | CA2353057A1 Topical treatment of skin |
| 01/13/2002 | CA2312051A1 Methylated nucleotide regulation of gene expression |
| 01/10/2002 | WO2002003071A2 Modulators of trk protein activity, compositions and uses |
| 01/10/2002 | WO2002003070A1 Method for screening mch receptor antagonist/agonist |
| 01/10/2002 | WO2002003063A1 Use of disease-associated gene |
| 01/10/2002 | WO2002002819A1 Method of screening for chemotherapeutic treatments for cancer |
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002774A2 32626, a human udp-glycosyltransferase and uses thereof |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002771A2 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/10/2002 | WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | WO2002002762A1 Novel lipase |
| 01/10/2002 | WO2002002760A2 25869, a human carboxylesterase and uses thereof |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002756A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002639A2 Human ion channels |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002630A2 Hcn polypeptides and polynucleotides and their use in therapy |
| 01/10/2002 | WO2002002628A1 Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002619A1 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof |
| 01/10/2002 | WO2002002613A1 A novel polypeptide - human oxysterol-binding protein 38.72 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002602A2 Slgp protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | WO2002002599A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF |